Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Drug Design, Development and Therapy|February 6, 2020
Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model AnalysisHan Yang, Nan Li, Youlian Zhou, et al.
Gut Microbes|April 11, 2025
Gut microbiota and epigenetic inheritance: implications for the development of IBDXue Guo, Jianhong Li, Jing Xu, et al.
Frontiers in Medicine|April 19, 2021
Deficiencies in Planning Interventional Trial Registration of COVID-19 in ChinaXiaodan Li, Shengzhao Zhang, Yiling Zhou, et al.
Frontiers in Nutrition|December 2, 2020
Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like MiceHanchang He, Haoming Xu, Jing Xu, et al.
Veterinary Medicine and Science|January 20, 2026
Diagnosis of Paralytic Rabies by Metagenomics Next-Generation Sequencing: A Case Report and Review of the LiteratureLianghai Cao, Xingyu Wang, Youlian Zhou, et al.
Microorganisms|April 26, 2025
Odoribacter splanchnicus-A Next-Generation Probiotic CandidateJianhong Li, Jing Xu, Xue Guo, et al.
European Journal of Gastroenterology & Hepatology|August 15, 2015
Infliximab for the treatment of Crohn's disease: efficacy and safety in a Chinese single-center retrospective studyYoulian Zhou, Hanchang He, Pu Wang, et al.
AMB Express|February 28, 2021
F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitisYoulian Zhou, Haoming Xu, Jing Xu, et al.
Frontiers in Nutrition|March 15, 2021
Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel DiseasesYoulian Zhou, Yan He, Le Liu, et al.
Gut Pathogens|December 8, 2021
Genome insights of Enterococcus raffinosus CX012922, isolated from the feces of a Crohn's disease patientHailan Zhao, Yao Peng, Xunchao Cai, et al.
Pageof 5